Published in Pain and Central Nervous System Week, December 25th, 2006
Unigene scientists, in collaboration with Agnes Vignery at Yale, co-invented the site-directed bone growth technology, which involves the use of a simple, minimally invasive outpatient procedure in conjunction with the administration of an anabolic drug that has been shown in animals to facilitate and accelerate natural bone growth at precisely targeted locations. Possible applications of this...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pain and Central Nervous System Week